Reckitt Benckiser Group PLC (LSE:RKT, FRA:3RB, ETR:3RB) reiterated guidance for the full year, saying trading in recent months is in line with management expectations.
The household products maker said like-for-like net revenue growth will be 0-2% and adjusted operating profit margins will be 22.7-23.2% in the year to December 2021.
READ: Reckitt Benckiser: Are the shares worth buying ahead of the company's investor day? Here's what one Wall Street bank thinks
The forecasts exclude the contribution of the infant formula and child nutrition (IFCN) business in China, which was sold to Primavera Capital for US$2.2bn including debt.
The transaction was completed earlier this month and the FTSE 100 group previously warned the market it would book a £2.5bn loss on the deal.